European Archives - European Medical Journal

Anxiety Trends in People with HCV Who Inject Drugs

This study aimed to explore anxiety trends among HCV-infected people who inject drugs.

FAB Score: A New Tool for Predicting Mortality in Adult Fontan

New research shows how the FAB Score predicts mortality risk in adult Fontan patients with 92% accuracy.

Prednisolone Initiation Before Specialist Visit Complicates Polymyalgia Rheumatica Diagnosis

Initiating steroid treatment before specialist evaluation may obscure the clinical signs of polymyalgia rheumatica, reducing diagnostic accuracy.

Pregnancy Blood Pressure Trajectories May Predict Long-Term Hypertension Risk

Gestational blood pressure trajectories are linked to long-term hypertension risk, highlighting the need for better postpartum monitoring.

Annual Lenacapavir Injection Could Revolutionise HIV PrEP

New findings highlight the potential of once-yearly intramuscular lenacapavir for PrEP, offering a long-acting alternative that could reduce barriers to HIV prevention.

Intestinal Ultrasound Detects Hidden IBD Risks During Pregnancy

A large international study shows that intestinal ultrasound during pregnancy can reveal hidden inflammatory bowel disease activity, significantly improving prediction of complications like preterm birth and preeclampsia, beyond what clinical symptoms and lab tests can detect.

Risk Factor Count Determines Skin Cancer Progression

From a therapeutic perspective, these findings advocate for a more tailored approach to treatment.

Broken Heart Syndrome: Machine Learning Identifies the Key Mortality Risks

Machine learning model predicts death risk in broken heart syndrome with 84% accuracy, a new study reveals.

Managing Catheter-Related Bladder Discomfort After Surgery

A randomised pilot study investigated whether scheduled IV acetaminophen administration would offer longer-lasting relief than a single dose.

Minimal Residual Disease May Predict NSCLC Recurrence After Osimertinib

Molecular residual disease detection may help identify patients with EGFR-mutated NSCLC who could benefit from prolonged adjuvant osimertinib